IMRX – immuneering corporation - class a (US:NASDAQ)
Stock Stats
News
Immuneering to Present Molecular Data at 2026 AACR Annual Meeting from Atebimetinib-Treated Patients, Highlighting Mechanism Designed to Improve Durability and Survival [Yahoo! Finance]
Immuneering to Present Molecular Data at 2026 AACR Annual Meeting from Atebimetinib-Treated Patients, Highlighting Mechanism Designed to Improve Durability and Survival
Immuneering (IMRX) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $11.00 price target on the stock.
Immuneering (IMRX) was upgraded by Wall Street Zen from "sell" to "ho
Immuneering Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates [Yahoo! Finance]
Form 4 Immuneering Corp For: Mar 13 Filed by: Neufeld Leah R
Form 10-K Immuneering Corp For: Dec 31
Form 8-K Immuneering Corp For: Mar 06
Form 4 Immuneering Corp For: Feb 03 Filed by: Bookman Michael
Form 4 Immuneering Corp For: Feb 03 Filed by: Brakewood Harold Eugene
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.